作者: Makoto Nakamuta , Masamichi Koyanagi , Ken-ichi Nishida , Kensuke Egashira , Akira Takeshita
DOI:
关键词:
摘要: Preventives and/or remedies for liver diseases, which comprise monocyte chemoattractant protein-I (MCP-I) function inhibitors as active ingredients, respectively. Administration of the MCP-I brings about effects in preventing remedying diseases.